Novyra Pharmachem share news, announcements and annual reports
BSE: 519353Agricultural Food & other ProductsSmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹8.50.
28 Oct: open ₹8.08, high ₹8.08, low ₹8.08
- Under BSE's graded surveillance, stage 0, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 2 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5.11 Cr4,706th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.64
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −166.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −906.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 200
Novyra Pharmachem has 390 announcements on record, routine notices left out; 2 in the 30 days to 29 Oct 2026, the latest on 23 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Novyra Pharmachem quarterly results
The board meets on 2 Nov 2026 to consider quarterly results
Notice filed 23 Oct 2026
Novyra Pharmachem annual reports, presentations and earnings calls
The company's own documents, latest first.Novyra Pharmachem financials, year by year
Annual reports29
- Annual report, year to Mar 20265 Jun 2026
- Annual report, year to Mar 202116 Dec 2025
- Annual report, year to Mar 20256 Sep 2025
- Annual report, year to Mar 20249 Sep 2024
- Annual report, year to Mar 20231 Jan 2024
24 earlier reports
- Annual report, year to Mar 20223 Sep 2022
- Annual report, year to Mar 20202 Sep 2020
- Annual report, year to Mar 20191 Oct 2019
- Annual report, year to Mar 20184 Oct 2018
- Annual report, year to Mar 20175 Oct 2017
- Annual report, year to Mar 20169 Sep 2016
- Annual report, year to Mar 20155 Feb 2016
- Annual report, year to Mar 20145 Feb 2016
- Annual report, year to Mar 2013Filing day not known
- Annual report, year to Mar 20125 Oct 2012
- Annual report, year to Mar 201025 May 2012
- Annual report, year to Mar 201126 Mar 2012
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 2002Filing day not known
- Annual report, year to Mar 2001Filing day not known
- Annual report, year to Mar 2000Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1997Filing day not known
Novyra Pharmachem share news and announcements
Newest first. Page 1 of 8.
Oct 2026
23 Oct · Board meeting
Meeting on 2 Nov 2026: quarterly results
Sep 2026
24 Sep
Aug 2026
22 Aug
14 Aug · Results
14 Aug · Results
11 Aug · Board meeting
Meeting on 14 Aug 2026: quarterly results4 Aug
Jun 2026
26 Jun · Results
25 Jun · Meeting
1 Jun · Meeting
May 2026
30 May
26 May · Board meeting
Meeting on 26 May 2026: reduction of capital and annual general meeting26 May · Meeting
26 May · Board meeting
16 May · Board meeting
4 May · Board meeting
Meeting on 16 May 2026: reduction of capital
Apr 2026
29 Apr · Board meeting
Meeting on 2 May 2026: audited results27 Apr · Board meeting
Meeting on 29 Apr 2026: audited resultsNot held on this date
Mar 2026
20 Mar · Board meeting
11 Mar · Board meeting
Meeting on 20 Mar 2026
Feb 2026
6 Feb · Management
6 Feb · Board meeting
Jan 2026
26 Jan · Results
22 Jan · Board meeting
Meeting on 26 Jan 2026: quarterly results8 Jan · Board meeting
Meeting on 22 Jan 2026: quarterly resultsNot held on this date
Dec 2025
5 Dec · Intimation Of Receipt Of Order From Regional Director (Eastern Region), Kolkata For Shifting Of Registered Office From The State Of West Bengal To The State Of Gujarat.
Nov 2025
28 Nov · Meeting
22 Nov · Management
19 Nov · Management
19 Nov · Board meeting
13 Nov · Board meeting
Meeting on 19 Nov 2025
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 10 Dec 2025Order received–market median +1.1% · five sessions +5.8% (+6.4 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 25 Nov 2025Board or managers changedup 5.00%+5.6 pts vs Nifty 500market median 0.0% · five sessions +23.7% (+23.6 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 21 Nov 2025Board or managers changedup 4.96%+5.4 pts vs Nifty 500market median 0.0% · five sessions +27.4% (+27.3 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 5 Sep 2024Board or managers changedup 4.99%+4.9 pts vs Nifty 500market median 0.0% · five sessions +19.9% (+17.7 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 6 Nov 2017Board or managers changed–market median 0.0% · The announcement
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Employee costs | Quarter to Jun 2022 | Standalone | 0.01 | 0.01 | +0.1% | 6 Sep 2022 | 25 Nov 2022 |
| Other expenses | Quarter to Jun 2022 | Standalone | 0.04 | 0.04 | 0.0% | 6 Sep 2022 | 25 Nov 2022 |
| Total expenses | Quarter to Jun 2022 | Standalone | 0.05 | 0.05 | 0.0% | 6 Sep 2022 | 25 Nov 2022 |
| Profit before tax | Quarter to Jun 2022 | Standalone | −0.02 | −0.02 | −0.1% | 6 Sep 2022 | 25 Nov 2022 |
| Net profit | Quarter to Jun 2022 | Standalone | −0.02 | −0.02 | −0.1% | 6 Sep 2022 | 25 Nov 2022 |
| Profit before one-off items and tax | Quarter to Jun 2022 | Standalone | −0.02 | −0.02 | −0.1% | 6 Sep 2022 | 25 Nov 2022 |
| Net profit from continuing businesses | Quarter to Jun 2022 | Standalone | −0.02 | −0.02 | −0.1% | 6 Sep 2022 | 25 Nov 2022 |
| Total comprehensive income | Quarter to Jun 2022 | Standalone | −0.02 | −0.02 | −0.1% | 6 Sep 2022 | 25 Nov 2022 |